Bank of America’s Windtree Therapeutics Inc WINT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-71
Closed -$2K 8367
2014
Q1
$2K Buy
+71
New +$2.39K ﹤0.01% 7566

Other funds holding WINT

Bank of America's WINT Position: Q2 2017 in Review

Bank of America sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 610 shares — an estimated $1K sold.

Bank of America first reported a position in WINT in Q2 2013 and held it in 16 quarters. The position peaked at $164K in Q2 2013. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

  • Bank of America reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • Bank of America sold 610 Windtree Therapeutics Inc shares in Q2 2017, an estimated $1K.
  • Bank of America first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 16 quarters.
  • Bank of America's Windtree Therapeutics Inc position peaked at $164K in Q2 2013.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on Bank of America's 13F filing for Q2 2017, filed 14 Aug 2017.